HIV/AIDS News and Research

RSS

Acquired immune deficiency syndrome or acquired immunodeficiency syndrome (AIDS) is a disease of the human immune system caused by the human immunodeficiency virus (HIV).

Global Alliance for Chronic Disease to fight against chronic non-communicable diseases

An alliance of institutions collectively managing an estimated 80 percent of all public health research funding worldwide today announced their first targets for concerted action in the fight against "chronic non-communicable diseases" (CNCDs).

17 Nov 2009

Power of prevention in women's hands: NYC scales up access to the second-generation female condom

African Services Committee is praising New York City's Department of Health, for showing national leadership in putting the second-generation female condom into the hands of women living with or at risk of HIV/AIDS infection.

17 Nov 2009

CD4 Initiative selects Zyomyx's CD4 POC technology as best for measuring CD4 T-cell count in HIV/AIDS patients

Zyomyx, Inc., a leader in chip-based bioanalysis technologies, today announced that its readerless CD4 point-of-care (POC) technology was selected by Imperial College London's CD4 Initiative as the best-performing POC test method for measuring CD4 T-cell count in HIV/AIDS patients. Zyomyx's CD4 assay is now the only remaining POC product being supported by the CD4 Initiative.

17 Nov 2009

Economic crisis impacts health department capacity to address rising STD rates

Amid the mounting toll of budget cuts across the country, a new study from the National Coalition of STD Directors (NCSD) shows just how much an impact the economic crisis is having on sexually transmitted disease (STD) programs and in turn, having more broadly on public health infrastructure.

17 Nov 2009

Targeted Genetics announces third quarter 2009 results; reports net income of $0.03 per common share

Targeted Genetics Corporation today announced its financial results for the third quarter ended September 30, 2009.

17 Nov 2009

Los Angeles Times examines health care in Sierra Leone

The Los Angeles Times writes: "Sierra Leone is one of those nations where decades of foreign aid have failed to appreciably lift the fortunes of the people. The country is a charity case: 60% of its public spending comes from foreign governments and nonprofit organizations.

16 Nov 2009

Opinions: Health system funding; malnutrition assistance; social dimension of HIV

"For too long, global health funding has gone to diseases like AIDS with the most vocal lobby groups and not to the diseases with the greatest need," Philip Stevens, a senior fellow at International Policy Network, writes in a Business Daily opinion piece.

16 Nov 2009

Also in Global Health News: HIV/AIDS in Uganda; medical equipment in Tanzania; birth control in Afghanistan; Ethiopia malaria fight

"The Uganda AIDS Commission (UAC) is revamping its national HIV information campaign after HIV prevention messages were less successful than hoped," PlusNews reports. "Campaigns aimed at ending cross-generational sex will be abandoned in favour of generic warnings about engaging in risky sex because of fears that young people may believe that sex within their own generation is risk-free. Officials have also said factors such as alcohol abuse, which predispose people to risky sexual behaviour, must be tackled alongside HIV prevention" (11/16).

16 Nov 2009

Researchers, decision makers, and people with HIV to attend Ontario HIV Treatment Network's conference

The 11th annual research conference of the Ontario HIV Treatment Network will examine the factors that increase risk for individuals and communities most affected by HIV, as well as interventions that may improve the lives of people living with HIV and prevent the spread of the virus.

16 Nov 2009

SPOT: A one-stop HIV and sexually transmitted diseases testing center for youth

In the last 10 years, the St. Louis area has seen an alarming increase in new diagnoses of HIV and sexually transmitted infections among 13-24 year-olds. Between 1997-2007, more than 50 new diagnoses of HIV were made each year among adolescents and young adults, who are often disconnected from the health-care system or support services. Nationwide, St. Louis has among the highest rates of sexually transmitted diseases in this age group.

16 Nov 2009

Inovio Biomedical reports financial results for the three and nine months ended September 30, 2009

Inovio Biomedical Corporation today reported financial results for the three and nine months ended September 30, 2009.

16 Nov 2009

New faces of HIV/AIDS: A report

World AIDS Day 2009 will be marked with both grim and hopeful data: more than 25 million people have died of AIDS worldwide since 1981; 33 million are living with HIV/AIDS. While potent, effective medications have changed an HIV diagnosis from death sentence to manageable chronic illness in resource rich countries, global rates of infection still outstrip prevention and treatment capacity.

16 Nov 2009

Recent releases in Global Health

As a follow-up to a survey conducted in May 2009, this poll examines Americans' attitudes toward U.S. global health investments and priorities.

16 Nov 2009

NIDA awards $17 million to University of California to establish TMARC

Igor Grant, MD, professor of psychiatry at the University of California, San Diego School of Medicine, and colleagues have been awarded a $17 million grant from the National Institute on Drug Abuse to establish the Translational Methamphetamine AIDS Research Center (TMARC) at UC San Diego. Grant is director of the HIV Neurobehavioral Research Center (HNRC), a clinical research center designated and funded by the National Institute of Mental Health.

16 Nov 2009

Chembio Diagnostics to donate more than 4,500 rapid HIV test kits

Chembio Diagnostics, Inc., a NY-based company that develops, manufactures, licenses and markets proprietary rapid diagnostic tests, is donating more than 4,500 rapid HIV test kits to the AIDS Healthcare Foundation's 2009 Testing Millions Global Campaign, based in Los Angeles, to commemorate World AIDS Day 2009 on December 1st.

16 Nov 2009

Global Fund approves $2.4B for ninth round grants

During its recent board meeting in Addis Ababa, Ethiopia, the Global Fund to Fight AIDS, Tuberculosis and Malaria approved $2.4 billion for the three diseases, PlusNews reports.

16 Nov 2009

DC HIV study: Can intense treatment prevent spread

The Washington Post: "The National Institutes of Health and the D.C. Health Department are preparing to launch a study in the District with an ambitious goal: to determine whether aggressive treatment of every adult with HIV could eliminate AIDS." In conjunction with the study, NIH will provide experts to the city health department to help modernize clinic record-keeping efforts and to improve the tracking of HIV-infected people.

13 Nov 2009

Scientists describe how HIV assemble at the membrane of infected cells and are released to attack healthy cells

Although recent advances have raised hopes that a protective vaccine can be developed, acquired immunodeficiency syndrome (AIDS) remains a major public health problem. Much has been learned about HIV-1, the virus that causes the disease.

13 Nov 2009

Nutra Pharma to market its OTC pain reliever in Brazil and Colombia, begins the drug registration process

Nutra Pharma Corp., a biotechnology company that is developing treatments for Adrenomyeloneuropathy (AMN), HIV and Multiple Sclerosis (MS), has announced today that it plans to begin the drug registration process in Brazil and Colombia for its over-the-counter (OTC) pain reliever. The company is currently marketing a similar drug in the United States under the brand name Cobroxin for the treatment of moderate to severe (Stage 2) chronic pain.

13 Nov 2009

New findings on human genome may be useful for developing specific AIDS drugs

The AIDS virus inserts its genetic material into the genome of the infected cell. Scientists of the German Cancer Research Center have now shown for the first time that the virus almost entirely spares particular sites in the human genetic material in this process. This finding may be useful for developing new, specific AIDS drugs.

13 Nov 2009

HIV/AIDS News and Research

Further Reading

Global Alliance for Chronic Disease to fight against chronic non-communicable diseases

Power of prevention in women's hands: NYC scales up access to the second-generation female condom

CD4 Initiative selects Zyomyx's CD4 POC technology as best for measuring CD4 T-cell count in HIV/AIDS patients

Economic crisis impacts health department capacity to address rising STD rates

Targeted Genetics announces third quarter 2009 results; reports net income of $0.03 per common share

Los Angeles Times examines health care in Sierra Leone

Opinions: Health system funding; malnutrition assistance; social dimension of HIV

Also in Global Health News: HIV/AIDS in Uganda; medical equipment in Tanzania; birth control in Afghanistan; Ethiopia malaria fight

Researchers, decision makers, and people with HIV to attend Ontario HIV Treatment Network's conference

SPOT: A one-stop HIV and sexually transmitted diseases testing center for youth

Inovio Biomedical reports financial results for the three and nine months ended September 30, 2009

New faces of HIV/AIDS: A report

Recent releases in Global Health

NIDA awards $17 million to University of California to establish TMARC

Chembio Diagnostics to donate more than 4,500 rapid HIV test kits

Global Fund approves $2.4B for ninth round grants

DC HIV study: Can intense treatment prevent spread

Scientists describe how HIV assemble at the membrane of infected cells and are released to attack healthy cells

Nutra Pharma to market its OTC pain reliever in Brazil and Colombia, begins the drug registration process

New findings on human genome may be useful for developing specific AIDS drugs

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News